Opdualag is a fixed-dose combination of nivolumab, a programmed death receptor-1 blocking antibody, and relatlimab, a lymphocyte activation gene 3 blocking antibody.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback